These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7618043)

  • 41. Anemia of chronic renal failure: treatment with erythropoietin.
    Navarro M; Alonso A; Avilla JM; Espinosa L
    Child Nephrol Urol; 1991; 11(3):146-51. PubMed ID: 1777893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness of low-dose erythropoietin in predialysis chronic renal failure patients.
    Mitwalli A; Abuaisha H; al Wakeel J; al Mohaya S; Alam AA; el Gamal H; Fayed H
    Nephrol Dial Transplant; 1993; 8(10):1085-8. PubMed ID: 8272220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased endothelin: nitric oxide ratio is associated with erythropoietin-induced hypertension in hemodialysis patients.
    Shimada N; Saka S; Sekizuka K; Tanaka A; Takahashi Y; Nakamura T; Ebihara I; Koide H
    Ren Fail; 2003 Jul; 25(4):569-78. PubMed ID: 12911161
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of withdrawing ACE inhibitors on erythropoietin responsiveness and left ventricular hypertrophy in haemodialysis patients.
    Ertürk S; Nergizoğlu G; Ateş K; Duman N; Erbay B; Karatan O; Ertuğ AE
    Nephrol Dial Transplant; 1999 Aug; 14(8):1912-6. PubMed ID: 10462270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute effects of recombinant human erythropoietin on plasma levels of proendothelin-1 and endothelin-1 in haemodialysis patients.
    Kang DH; Yoon KI; Han DS
    Nephrol Dial Transplant; 1998 Nov; 13(11):2877-83. PubMed ID: 9829494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic predisposition to hypertension facilitates blood pressure elevation in hemodialysis patients treated with erythropoietin.
    Ishimitsu T; Tsukada H; Ogawa Y; Numabe A; Yagi S
    Am J Med; 1993 Apr; 94(4):401-6. PubMed ID: 8475933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood pressure response to erythropoietin injection in hemodialysis and predialysis patients.
    Miyashita K; Tojo A; Kimura K; Goto A; Omata M; Nishiyama K; Fujita T
    Hypertens Res; 2004 Feb; 27(2):79-84. PubMed ID: 15005270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in intravenous and subcutaneous application of recombinant human erythropoietin: a multicenter trial.
    Schaller R; Sperschneider H; Thieler H; Dutz W; Hans S; Voigt D; Marx M; Engelmann J; Schöter KH; Scigalla P
    Artif Organs; 1994 Aug; 18(8):552-8. PubMed ID: 7993190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subcutaneous erythropoietin therapy: efficacy and economic implications.
    Kaufman JS
    Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S147-51. PubMed ID: 9892382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers.
    McMahon FG; Vargas R; Ryan M; Jain AK; Abels RI; Perry B; Smith IL
    Blood; 1990 Nov; 76(9):1718-22. PubMed ID: 2224121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypertension following erythropoietin therapy in anemic hemodialysis patients.
    Buckner FS; Eschbach JW; Haley NR; Davidson RC; Adamson JW
    Am J Hypertens; 1990 Dec; 3(12 Pt 1):947-55. PubMed ID: 2127895
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of recombinant human erythropoietin applied subcutaneously to children with chronic renal failure.
    Braun A; Ding R; Seidel C; Fies T; Kurtz A; Schärer K
    Pediatr Nephrol; 1993 Feb; 7(1):61-4. PubMed ID: 8439481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proof-of-concept study on improved efficacy of rHuEPO administered as a long-term infusion in rats.
    Szczesny D; Mołoniewicz K; Markuszewski MJ; Wiczling P
    Pharmacol Rep; 2020 Oct; 72(5):1264-1270. PubMed ID: 32748255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recombinant human erythropoietin utilization in Department of Veterans Affairs dialysis units.
    Wolfson M; Mundt DJ; Hawley GG
    Am J Kidney Dis; 1994 Aug; 24(2):184-91. PubMed ID: 8048423
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiplatelet therapy and development of hypertension induced by recombinant human erythropoietin in uremic patients.
    Caravaca F; Pizarro JL; Arrobas M; Cubero JJ; García MC; Perez-Miranda M
    Kidney Int; 1994 Mar; 45(3):845-51. PubMed ID: 8196287
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Must erythropoietin be injected by the subcutaneous route for every hemodialyzed patient?
    Virot JS; Janin G; Guillaumie J; Michel P; Dubot P; Chevet D; Rifle G
    Am J Kidney Dis; 1996 Sep; 28(3):400-8. PubMed ID: 8804239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Haemoglobin mass and running time trial performance after recombinant human erythropoietin administration in trained men.
    Durussel J; Daskalaki E; Anderson M; Chatterji T; Wondimu DH; Padmanabhan N; Patel RK; McClure JD; Pitsiladis YP
    PLoS One; 2013; 8(2):e56151. PubMed ID: 23418527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early and late effects of erythropoietin on glucose metabolism in maintenance hemodialysis patients.
    Allegra V; Mengozzi G; Martimbianco L; Vasile A
    Am J Nephrol; 1996; 16(4):304-8. PubMed ID: 8739283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coagulation studies and fistula blood flow during erythropoietin therapy in haemodialysis patients.
    Macdougall IC; Davies ME; Hallett I; Cochlin DL; Hutton RD; Coles GA; Williams JD
    Nephrol Dial Transplant; 1991; 6(11):862-7. PubMed ID: 1837851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does intravenous erythropoietin lead to an immediate, transient increase in arterial blood pressure in dialysis patients?
    Touam M; Perez Oliva J; Zingraff J; Drüeke T
    Nephron; 1994; 67(2):240-1. PubMed ID: 8072618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.